TrialFuture science OA2021

A Phase I study of pevonedistat plus capecitabine plus oxaliplatin in patients with advanced gastric cancer refractory to platinum (NCCH-1811).

Hirokazu Shoji et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.